These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16883018

  • 1. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
    Zhao M, Zhu X, Ji S, Zhou J, Ozker KS, Fang W, Molthen RC, Hellman RS.
    J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
    [Abstract] [Full Text] [Related]

  • 2. Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion.
    Zhu X, Li Z, Zhao M.
    J Nucl Med; 2007 Jun; 48(6):1031-6. PubMed ID: 17536109
    [Abstract] [Full Text] [Related]

  • 3. [Technetium-99m labeled synaptotagmin I C2A detection of paclitaxel-induced apoptosis in non-small cell lung cancer].
    Wang F, Fang W, Ji SD, Meng QL, Li Y, Fan KW, Wang ZZ.
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):351-4. PubMed ID: 17892130
    [Abstract] [Full Text] [Related]

  • 4. Early uptake of 99mTc-C2A in the acute phase of myocardial infarction as a prognostic indicator for follow-up cardiac dysfunction.
    Zhu X, Migrino RQ, Hellman RS, Brahmbhatt T, Zhao M.
    Nucl Med Commun; 2008 Sep; 29(9):764-9. PubMed ID: 18677202
    [Abstract] [Full Text] [Related]

  • 5. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
    Tavaré R, Torres Martin De Rosales R, Blower PJ, Mullen GE.
    Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
    [Abstract] [Full Text] [Related]

  • 6. In vivo dynamic imaging of myocardial cell death using 99mTc-labeled C2A domain of synaptotagmin I in a rat model of ischemia and reperfusion.
    Liu Z, Zhao M, Zhu X, Furenlid LR, Chen YC, Barrett HH.
    Nucl Med Biol; 2007 Nov; 34(8):907-15. PubMed ID: 17998092
    [Abstract] [Full Text] [Related]

  • 7. Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: a preliminary study.
    Wang F, Fang W, Zhao M, Wang Z, Ji S, Li Y, Zheng Y.
    Nucl Med Biol; 2008 Apr; 35(3):359-64. PubMed ID: 18355692
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of [99mTc]C2A-GST distribution in the area at risk after myocardial ischemia and reperfusion using a compartmental model.
    Audi S, Poellmann M, Zhu X, Li Z, Zhao M.
    Nucl Med Biol; 2007 Nov; 34(8):897-905. PubMed ID: 17998091
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of chemotherapy response in VX2 rabbit lung cancer with 18F-labeled C2A domain of synaptotagmin I.
    Wang F, Fang W, Zhang MR, Zhao M, Liu B, Wang Z, Hua Z, Yang M, Kumata K, Hatori A, Yamasaki T, Yanamoto K, Suzuki K.
    J Nucl Med; 2011 Apr; 52(4):592-9. PubMed ID: 21421722
    [Abstract] [Full Text] [Related]

  • 10. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A.
    Bioconjug Chem; 2007 Apr; 18(6):1924-34. PubMed ID: 17929883
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 Apr; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.
    Alam IS, Neves AA, Witney TH, Boren J, Brindle KM.
    Bioconjug Chem; 2010 May 19; 21(5):884-91. PubMed ID: 20402461
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.
    J Nucl Med; 2008 May 19; 49(5):788-95. PubMed ID: 18413403
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM, Tofe AJ, Kulkarni PV, Mukherjee A, Parkey RW, Francis MD, Bonte FJ, Willerson JT.
    J Clin Invest; 1977 Sep 19; 60(3):724-40. PubMed ID: 893676
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M, Wang RF, Zhang CL, Yan P, Yu MM, Di LJ, Liu HJ, Guo FQ.
    J Nucl Med; 2007 Dec 19; 48(12):2028-36. PubMed ID: 18006621
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe.
    Zhao M, Li Z, Bugenhagen S.
    J Nucl Med; 2008 Aug 19; 49(8):1345-52. PubMed ID: 18632826
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.